Sunlenca (lenacapavir) Patient Assistance Program
Don’t let the high cost of brand long-acting HIV capsid inhibitor disrupt your multi-drug-resistant HIV treatment. We help eligible patients access Sunlenca (lenacapavir tablets and subcutaneous injection) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Sunlenca (lenacapavir) is FDA-approved for treatment of heavily treatment-experienced adults with multidrug-resistant HIV-1 infection, in combination with other antiretroviral(s). First-in-class HIV-1 capsid inhibitor — long-acting subcutaneous injection every 6 months (after initial oral/SC loading). Also under study/newer approval for HIV-1 pre-exposure prophylaxis (PrEP).
- Without assistance, Sunlenca costs commonly run approximately $42,000 per year (~$3,500 per month).
- Through AffordMyPrescriptions, qualifying patients can access Sunlenca for a flat $69.95 per month.
- Other HIV regimens: Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide — most-prescribed single-tablet HIV regimen), Dovato (dolutegravir/lamivudine — 2-drug single tablet), Triumeq (dolutegravir/abacavir/lamivudine), Cabenuva (cabotegravir + rilpivirine long-acting IM injections every 1–2 months), and older single-tablet regimens (many now generic — Complera, Atripla generic, Symfi). Sunlenca is specifically for heavily treatment-experienced patients with multidrug resistance where standard regimens have failed. Every-6-month dosing after loading is unique.
What is Sunlenca Prescription Assistance Program?
The Sunlenca Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Sunlenca (used for heavily treatment-experienced adults with multidrug-resistant HIV) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but enrollment involves detailed applications, HIV specialist coordination, resistance test documentation, and ongoing renewal.
At AffordMyPrescriptions, our Patient Advocates handle the entire Sunlenca PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your HIV specialist for required medical documentation (resistance testing, prior treatment history), follow up with the manufacturer’s program until approval, manage your refills, and handle annual re-certification — so you never face a gap in your Sunlenca HIV therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Sunlenca enrollment — from the initial application through ongoing subcutaneous injections and annual re-enrollment — so you never face a gap in your multidrug-resistant HIV treatment.
Pharmacy Price Comparison
- Without assistance, Sunlenca costs tens of thousands of dollars per year at specialty pharmacies. A Patient Assistance Program can make this HIV capsid inhibitor accessible if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Ryan White HIV/AIDS Program | programs | State AIDS Drug Assistance Programs |
| Walgreens Specialty | ~$42,500/yr | Save substantially |
| CVS Specialty | ~$43,000/yr | Save substantially |
| Walmart Specialty | ~$41,000/yr | Save substantially |
| Specialty pharmacy | ~$40,000/yr | Save substantially |
| 340B-eligible institution | ~$35,000/yr | Save substantially |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Sunlenca — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Sunlenca Prescription Program?
The Sunlenca Patient Assistance Program is free to apply and provides medication at no cost if approved. Our $69.95 per month covers full advocacy. Ryan White HIV/AIDS Program and AIDS Drug Assistance Programs (ADAP) may also be available for uninsured or underinsured patients with HIV.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Sunlenca assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Sunlenca is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Sunlenca:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $35,000–$43,000/yr per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Sunlenca assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Sunlenca Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Sunlenca:
Sunlenca is the first-in-class HIV-1 capsid inhibitor with a unique multi-stage mechanism — inhibits capsid function during multiple steps of HIV replication (nuclear entry, virion maturation, capsid assembly). Long half-life enables every-6-month subcutaneous dosing after loading — extraordinary long-acting antiretroviral profile.
How It Works:
HIV-1 infection with multidrug resistance is a serious challenge — patients on failing regimens accumulate resistance mutations that limit remaining active drug options. Historically, heavily treatment-experienced patients with resistance to multiple drug classes had very few viable regimen options. Newer agents targeting novel mechanisms (attachment inhibitors, capsid inhibitors, maturation inhibitors) expand options. Lenacapavir is a small molecule that binds HIV-1 capsid protein at a novel site — inhibits multiple steps: nuclear entry, virion assembly, and capsid formation. Multi-step inhibition and high potency give lenacapavir unique properties. Extraordinarily long tissue half-life enables subcutaneous injection every 6 months after loading dose. Effective as part of combination regimen for heavily treatment-experienced patients with resistance.
Form and Use:
Sunlenca oral tablets (300 mg) and subcutaneous injection (927 mg/1.5 mL). Loading regimen: Day 1: 600 mg oral (2 × 300 mg tablets), Day 2: 600 mg oral, Day 8: 300 mg oral, Day 15: 927 mg SC (2 × 463.5 mg injections in abdomen). Maintenance: 927 mg SC every 26 weeks (6 months). Alternative loading regimens exist. Must be combined with optimized background HIV regimen. HIV specialist prescribing.
Generic Availability:
No generic Sunlenca. Other long-acting HIV therapy: Cabenuva (cabotegravir + rilpivirine — IM every 1–2 months for virologically suppressed, treatment-experienced or PrEP). Other HIV regimens (many oral daily): Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide — most commonly prescribed single-tablet HIV regimen — brand), Dovato (dolutegravir/lamivudine — 2-drug single tablet), Triumeq (dolutegravir/abacavir/lamivudine), Odefsey, Symtuza, and multiple generic single-tablet or multi-tablet regimens including generic Atripla (efavirenz/emtricitabine/tenofovir DF), Complera generic, Symfi. Older individual generics (efavirenz, lamivudine, tenofovir DF, emtricitabine, abacavir, dolutegravir generic recently, others). Sunlenca is reserved for treatment-experienced patients with multidrug resistance. Ryan White HIV/AIDS Program funds treatment for uninsured/underinsured; state ADAP programs; HIV Medicine Association and other advocacy resources.
Warnings:
Immune reconstitution inflammatory syndrome (IRIS) upon initiation (can unmask underlying infections — monitor), residual concentration and long half-life implications (pharmacological tail up to a year — resistance risk with delayed reinitiation or interruption; drug interactions may persist), injection site reactions (very common — pain, swelling, erythema, nodules, indurations lasting weeks), potential drug interactions (moderate CYP3A4 inhibitor, P-gp and OATP inhibitor — check all concomitant meds), embryo-fetal considerations. Other: nausea, headache. Drug interactions: rifampin contraindicated (strong CYP3A4 inducer). Coordinate with HIV specialist for entire regimen. HIV medication planning is a specialist decision that requires resistance testing, prior treatment history review, and comprehensive regimen optimization.
FAQ (Frequently Asked Questions)
How much does Sunlenca cost without insurance?
$42,000 per year (~$3,500 per month) at retail specialty pharmacy. Long-acting regimens like Sunlenca and Cabenuva are the most expensive HIV therapies. Standard daily oral regimens range from generic (Atripla generic ~$40/mo) to brand (Biktarvy ~$4,000/mo).
How is Sunlenca different from other HIV medications?
Sunlenca is the first HIV-1 capsid inhibitor — novel mechanism inhibiting multiple steps of HIV replication. Uniquely, dosed every 6 months by subcutaneous injection (after loading) — only long-acting antiretroviral with this schedule. Specifically approved for heavily treatment-experienced patients with multidrug resistance where standard regimens have failed. Must be combined with other active antiretrovirals.
Is Sunlenca a PrEP option?
Sunlenca (lenacapavir) is currently FDA-approved for treatment of multidrug-resistant HIV. Lenacapavir under a different brand or expanded indication may be approved for HIV pre-exposure prophylaxis (PrEP) — the every-6-month SC injection dosing shows revolutionary promise for PrEP adherence. Discuss current PrEP options with your HIV specialist.
How is Sunlenca administered?
Loading regimen combining oral tablets and initial subcutaneous injection over the first 2 weeks, then subcutaneous injection every 26 weeks (6 months) maintenance. SC injections are given in abdomen at HIV specialty clinic or eligible pharmacy. Regular follow-up with HIV specialist needed.
What is 'multidrug-resistant HIV' and who is Sunlenca for?
HIV-1 resistant to multiple antiretroviral drug classes limits treatment options. Sunlenca is FDA-approved for heavily treatment-experienced adults with multidrug-resistant HIV who cannot construct a suppressive regimen with standard agents. Combined with optimized background regimen. Requires HIV specialist evaluation with resistance testing.
Take Control of Your Medication Costs
HIV treatment must not lapse — resistance and viral rebound are serious risks. Our advocacy team is ready — for a flat $69.95 per month. If we cannot help you access Sunlenca, you are not charged.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.